Dr. Albert Bourla, Pfizer CEO
In November 2021, Taiwanese officials announced they will suspend second doses of the Pfizer vaccine to teens due to the risk of myocarditis and pericarditis.
Taiwan officials made the decision after examining US data where teens are still encouraged to take the shot.
In January 2022, Sweden announced it will not recommend Covid vaccines for children ages 5 to 11 because they do not see a clear benefit for doing so.
“With the knowledge we have today, with a low risk for serious disease for kids, we don’t see any clear benefit with vaccinating them,” Health Agency official Britta Bjorkholm said during a news conference, Reuters reported.
In September 2022, Danish officials announced they will bar people under 50 from receiving the COVID vaccine.
In early October 2022, Florida Surgeon General Dr. Joseph Ladapo announced there was an 84% increase in the incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination. That is a huge number!
In October 2022, a German study found that one in every 700 children under the age of five who received the Pfizer mRNA Covid vaccine was hospitalized with severe adverse events (SAE), and one in every 200 children had ‘symptoms that were currently ongoing and thus of unknown significance.’
There is absolutely no need for healthy children to receive the dangerous COVID-19 experimental vaccines.
Now a British children’s advocacy group has filed suit against Pfizer CEO Albert Bourla for making dishonest claims in order to push the dangerous vaccines on children.
The Telegraph reported:
Dr Albert Bourla used an interview with the BBC last December to claim that “there is no doubt in my mind that the benefits, completely, are in favour of” vaccinating youngsters aged five to 11 against Covid-19.
He argued that “Covid in schools is thriving” adding: “This is disturbing, significantly, the educational system, and there are kids that will have severe symptoms.”
The interview was published on Dec 2 – before the vaccine had been approved by Britain’s medical regulator for this age group.
Shortly after the article’s publication, a complaint was submitted to the pharmaceutical watchdog – the Prescription Medicines Code of Practice Authority (PMCPA) – by UsForThem, a parent campaign group which was set up to promote the plight of children during the pandemic.
The complaint alleged that Dr Bourla’s remarks about the children’s vaccine were “disgracefully misleading” and “extremely promotional in nature”, arguing that it breached several clauses of the Association of the British Pharmaceutical Industry’s (ABPI) code of practice.
“There is simply no evidence that healthy schoolchildren in the UK are at significant risk from the SARS COV-2 virus and to imply that they are is disgracefully misleading,” they said.
In September 2021, the Joint Committee on Vaccination and Immunisation (JCVI), had advised against a mass roll-out for children aged 12-15, saying the “margin of benefit” was “considered too small” and citing the low risk to healthy children from the virus.